The groundbreaking therapy of the medication represents a significant advance in the management of type 2 diabetes. Unlike existing therapies, tirzepatide affects multiple pathways – the GLP-1 hormone and the GIP https://tirzepatidepeptide253019.theisblog.com/42443804/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment